EDGAR Filing Documents for 0001104659-23-121013

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001104659-23-121013

Filing Date

2023-11-24

Accepted

2023-11-24 16:05:13

Documents

Period of Report

2023-11-24

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	tm2331509d1_6k.htm	6-K	8987
2	EXHIBIT 99.1	tm2331509d1_ex99-1.htm	EX-99.1	10452
3	GRAPHIC	tm2331509d1_ex99-2img001.jpg	GRAPHIC	2873
	Complete submission text file	0001104659-23-121013.txt		24541

Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22

Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005

Calliditas Therapeutics AB (Filer) CIK: 0001795579 (see all company filings)